ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 543 filers reported holding ASTRAZENECA PLC in Q3 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $632,179,203 | -3.4% | 9,335,762 | +2.1% | 0.12% | -0.8% |
| Q2 2023 | $654,489,825 | +13.1% | 9,146,004 | +9.7% | 0.13% | +5.0% |
| Q1 2023 | $578,591,166 | +18.0% | 8,336,225 | +15.2% | 0.12% | +14.3% |
| Q4 2022 | $490,497,296 | +160.2% | 7,233,921 | +110.5% | 0.10% | +150.0% |
| Q3 2022 | $188,485,000 | +27.5% | 3,436,854 | +53.7% | 0.04% | +35.5% |
| Q2 2022 | $147,889,000 | -57.0% | 2,236,671 | -56.9% | 0.03% | -47.5% |
| Q1 2022 | $344,173,000 | +13.7% | 5,186,484 | -0.2% | 0.06% | +22.9% |
| Q4 2021 | $302,681,000 | -2.7% | 5,195,785 | +0.3% | 0.05% | -9.4% |
| Q3 2021 | $311,017,000 | +4.6% | 5,179,166 | +4.3% | 0.05% | +3.9% |
| Q2 2021 | $297,417,000 | +28.7% | 4,964,742 | +6.8% | 0.05% | +18.6% |
| Q1 2021 | $231,063,000 | -0.2% | 4,646,798 | +0.4% | 0.04% | -4.4% |
| Q4 2020 | $231,456,000 | -23.5% | 4,629,747 | -16.1% | 0.04% | -31.8% |
| Q3 2020 | $302,382,000 | +3.8% | 5,517,579 | +0.1% | 0.07% | -7.0% |
| Q2 2020 | $291,420,000 | +19.0% | 5,509,907 | +0.5% | 0.07% | 0.0% |
| Q1 2020 | $244,878,000 | +24.7% | 5,483,236 | +39.2% | 0.07% | +61.4% |
| Q4 2019 | $196,429,000 | -55.1% | 3,939,569 | -59.9% | 0.04% | -58.1% |
| Q3 2019 | $437,471,000 | +14.3% | 9,815,219 | +5.9% | 0.10% | +16.7% |
| Q2 2019 | $382,676,000 | +11.7% | 9,270,260 | +9.4% | 0.09% | +8.4% |
| Q1 2019 | $342,645,000 | +50.4% | 8,475,021 | +41.2% | 0.08% | +33.9% |
| Q4 2018 | $227,881,000 | -17.8% | 6,000,024 | -14.4% | 0.06% | -7.5% |
| Q3 2018 | $277,249,000 | +12.7% | 7,006,552 | +0.0% | 0.07% | +26.4% |
| Q2 2018 | $246,000,000 | +0.4% | 7,006,544 | 0.0% | 0.05% | -3.6% |
| Q1 2018 | $245,019,000 | +57.7% | 7,006,544 | +56.4% | 0.06% | +61.8% |
| Q4 2017 | $155,407,000 | +2.4% | 4,478,584 | +0.0% | 0.03% | 0.0% |
| Q3 2017 | $151,734,000 | +867.6% | 4,478,580 | +873.6% | 0.03% | +750.0% |
| Q2 2017 | $15,682,000 | +9.5% | 460,006 | +0.0% | 0.00% | +33.3% |
| Q1 2017 | $14,324,000 | +14.0% | 460,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $12,567,000 | -16.9% | 460,000 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $15,116,000 | +8.9% | 460,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $13,887,000 | -82.1% | 460,000 | -83.3% | 0.00% | -81.0% |
| Q1 2016 | $77,440,000 | +22.6% | 2,750,000 | +47.8% | 0.02% | +16.7% |
| Q4 2015 | $63,147,000 | +331.4% | 1,860,000 | +304.3% | 0.02% | +350.0% |
| Q3 2015 | $14,637,000 | -0.1% | 460,000 | +100.0% | 0.00% | 0.0% |
| Q2 2015 | $14,653,000 | -6.9% | 230,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $15,739,000 | -2.8% | 230,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $16,187,000 | -26.9% | 230,000 | -25.8% | 0.00% | -33.3% |
| Q3 2014 | $22,146,000 | -3.9% | 310,000 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $23,036,000 | -64.8% | 310,000 | -69.3% | 0.01% | -68.4% |
| Q1 2014 | $65,529,000 | -33.9% | 1,010,000 | -39.5% | 0.02% | -32.1% |
| Q4 2013 | $99,148,000 | +14.3% | 1,670,000 | 0.0% | 0.03% | +7.7% |
| Q3 2013 | $86,723,000 | +9.8% | 1,670,000 | 0.0% | 0.03% | 0.0% |
| Q2 2013 | $78,991,000 | – | 1,670,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |